Related references
Note: Only part of the references are listed.Targeting mutant p53 in cancer: a long road to precision therapy
Fiamma Mantovani et al.
FEBS JOURNAL (2017)
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer
Jennifer L. Bishop et al.
CANCER DISCOVERY (2017)
Whole-genome landscape of pancreatic neuroendocrine tumours
Aldo Scarpa et al.
NATURE (2017)
Reprogramming to resist
Kathleen Kelly et al.
SCIENCE (2017)
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer
Ping Mu et al.
SCIENCE (2017)
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
Sheng Yu Ku et al.
SCIENCE (2017)
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
Gurkan Mollaoglu et al.
CANCER CELL (2017)
Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas
Laura H. Tang et al.
CLINICAL CANCER RESEARCH (2016)
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer
Etienne Dardenne et al.
CANCER CELL (2016)
N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells
John K. Lee et al.
CANCER CELL (2016)
Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets
Natasha Rekhtman et al.
CLINICAL CANCER RESEARCH (2016)
Neuroendocrine Tumors of the Prostate: Emerging Insights from Molecular Data and Updates to the 2016 World Health Organization Classification
David S. Priemer et al.
ENDOCRINE PATHOLOGY (2016)
Genetic requirement for Mycl and efficacy of RNA Pol I inhibition in mouse models of small cell lung cancer
Dong-Wook Kim et al.
GENES & DEVELOPMENT (2016)
Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma
John T. Powers et al.
NATURE (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
Akash Kumar et al.
NATURE MEDICINE (2016)
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Himisha Beltran et al.
NATURE MEDICINE (2016)
Towards a new classification of gastroenteropancreatic neuroendocrine neoplasms
Mark Kidd et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma
Paul T. Nghiem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer
Nadine S. Jahchan et al.
CELL REPORTS (2016)
ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs
Mark D. Borromeo et al.
CELL REPORTS (2016)
Tumorigenic Activity of Merkel Cell Polyomavirus T Antigens Expressed in the Stratified Epithelium of Mice
Megan E. Spurgeon et al.
CANCER RESEARCH (2015)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
Inhibition of Pluripotency Networks by the Rb Tumor Suppressor Restricts Reprogramming and Tumorigenesis
Michael S. Kareta et al.
CELL STEM CELL (2015)
Merkel Cell Polyomavirus Small T Antigen Is Oncogenic in Transgenic Mice
Monique E. Verhaegen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
The Comparative Pathology of Genetically Engineered Mouse Models for Neuroendocrine Carcinomas of the Lung
Adi F. Gazdar et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin
Matthew G. Oser et al.
LANCET ONCOLOGY (2015)
Comprehensive genomic profiles of small cell lung cancer
Julie George et al.
NATURE (2015)
DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2
J. T. Poirier et al.
ONCOGENE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
Matthew J. Niederst et al.
NATURE COMMUNICATIONS (2015)
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer
Shusuke Akamatsu et al.
CELL REPORTS (2015)
Models of neuroendocrine prostate cancer
Lisa D. Berman-Booty et al.
ENDOCRINE-RELATED CANCER (2015)
A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies
K. Althoff et al.
ONCOGENE (2015)
Merkel Cell Polyomavirus Small T Antigen Induces Cancer and Embryonic Merkel Cell Proliferation in a Transgenic Mouse Model
Masahiro Shuda et al.
PLOS ONE (2015)
Extra-prostatic Transgene-associated Neoplastic Lesions in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) Mice
Lisa D. Berman-Booty et al.
TOXICOLOGIC PATHOLOGY (2015)
Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
Eva Tiensuu Janson et al.
ACTA ONCOLOGICA (2014)
Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation
Jonathan I. Epstein et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Targets in small cell lung cancer
Beverly A. Teicher
BIOCHEMICAL PHARMACOLOGY (2014)
Drugging MYCN through an Allosteric Transition in Aurora Kinase A
William Clay Gustafson et al.
CANCER CELL (2014)
High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development
Dong Lin et al.
CANCER RESEARCH (2014)
Genetic and Clonal Dissection of Murine Small Cell Lung Carcinoma Progression by Genome Sequencing
David G. McFadden et al.
CELL (2014)
Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma
Hsueh-Li Tan et al.
CLINICAL CANCER RESEARCH (2014)
Neuroendocrine Tumors of the Pancreas: Current Concepts and Controversies
Michelle D. Reid et al.
ENDOCRINE PATHOLOGY (2014)
PTEN Is a Potent Suppressor of Small Cell Lung Cancer
Min Cui et al.
MOLECULAR CANCER RESEARCH (2014)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4
Pilar Ramos et al.
NATURE GENETICS (2014)
Recurrent SMARCA4 mutations in small cell carcinoma of the ovary
Petar Jelinic et al.
NATURE GENETICS (2014)
Drugging the p53 pathway: understanding the route to clinical efficacy
Khoo Kian Hoe et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids
Lynnette Fernandez-Cuesta et al.
NATURE COMMUNICATIONS (2014)
MYC, MAX, and Small Cell Lung Cancer
Charles M. Rudin et al.
CANCER DISCOVERY (2014)
The prenatal origins of cancer
Glenn M. Marshall et al.
NATURE REVIEWS CANCER (2014)
Comparison of WHO Classifications (2004,2010), the Hochwald Grading System, and AJCC and ENETS Staging Systems in Predicting Prognosis in Locoregional Well-differentiated Pancreatic Neuroendocrine Tumors
Ta-Chiang Liu et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma
Markus Brockmann et al.
CANCER CELL (2013)
Punctuated Evolution of Prostate Cancer Genomes
Sylvan C. Baca et al.
CELL (2013)
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Resistant Disease
Kadoaki Ohashi et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Neuroendocrine tumours-challenges in the diagnosis and classification of pulmonary neuroendocrine tumours
M. A. den Bakker et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Development and Characteristics of Preclinical Experimental Models for the Research of Rare Neuroendocrine Bladder Cancer
Thomas Hofner et al.
JOURNAL OF UROLOGY (2013)
DNA Methylation Alterations Exhibit Intraindividual Stability and Interindividual Heterogeneity in Prostate Cancer Metastases
Martin J. Aryee et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Neuroendocrine tumors of the gynecologic tract: Select topics
Marjan Rouzbahman et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2013)
Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors
Shinichi Yachida et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Marcin Imielinski et al.
CELL (2012)
Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway
Hongbing Chen et al.
ENDOCRINE-RELATED CANCER (2012)
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non-Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
Thomas J. Lynch et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer
Anna V. Lapuk et al.
JOURNAL OF PATHOLOGY (2012)
An Integrated Genomic Approach to Identify Predictive Biomarkers of Response to the Aurora Kinase Inhibitor PF-03814735
Kenneth E. Hook et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Andrew V. Biankin et al.
NATURE (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Christopher E. Barbieri et al.
NATURE GENETICS (2012)
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
Charles M. Rudin et al.
NATURE GENETICS (2012)
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
Martin Peifer et al.
NATURE GENETICS (2012)
A framework for identification of actionable cancer genome dependencies in small cell lung cancer
Martin L. Sos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1
Lauren Averett Byers et al.
CANCER DISCOVERY (2012)
Prostate Epithelial Pten/TP53 Loss Leads to Transformation of Multipotential Progenitors and Epithelial to Mesenchymal Transition
Philip Martin et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
The origin of neuroendocrine tumors and the neural crest saga
Juan Rosai
MODERN PATHOLOGY (2011)
Neuroendocrine Prostate Cancer Xenografts With Large-Cell and Small-Cell Features Derived From a Single Patient's Tumor: Morphological, Immunohistochemical, and Gene Expression Profiles
Ana Aparicio et al.
PROSTATE (2011)
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Lecia V. Sequist et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
Himisha Beltran et al.
CANCER DISCOVERY (2011)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
Loss of p130 Accelerates Tumor Development in a Mouse Model for Human Small-Cell Lung Carcinoma
Bethany E. Schaffer et al.
CANCER RESEARCH (2010)
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
Jinru Shia et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Ionizing Radiation Induces Prostate Cancer Neuroendocrine Differentiation through Interplay of CREB and ATF2: Implications for Disease Progression
Xuehong Deng et al.
CANCER RESEARCH (2008)
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding et al.
NATURE (2008)
Clonal integration of a polyomavirus in human Merkel cell carcinoma
Huichen Feng et al.
SCIENCE (2008)
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
James Bean et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Determining prognosis in patients with pancreatic endocrine neoplasms: Can the WHO classification system be simplified?
Cristina R. Ferrone et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
Jeffrey A. Engelman et al.
SCIENCE (2007)
Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line:: A new perspective for an old model
Kirsten D. Mertz et al.
NEOPLASIA (2007)
Small cell carcinomas of the gastrointestinal tract: Clinicopathological features and treatment approach
Baruch Brenner et al.
SEMINARS IN ONCOLOGY (2007)
Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer
Zongxiang Zhou et al.
CANCER RESEARCH (2006)
Epithelial-stromal tumor of the seminal vesicles in the transgenic adenocarcinoma mouse prostate model
Y Tani et al.
VETERINARY PATHOLOGY (2005)
A novel knock-in prostate cancer model demonstrates biology similar to that of human prostate cancer and suitable for preclinical studies
MY Gabril et al.
MOLECULAR THERAPY (2005)
Knockin of SV40 Tag oncogene in a mouse adenocarcinoma of the prostate model demonstrates advantageous features over the transgenic model
WM Duan et al.
ONCOGENE (2005)
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
S Kobayashi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
An investigation of the effects of late-onset dietary restriction on prostate cancer development in the TRAMP mouse
AW Suttie et al.
TOXICOLOGIC PATHOLOGY (2005)
Hepsin promotes prostate cancer progression and metastasis
O Klezovitch et al.
CANCER CELL (2004)
The Sema domain of Met is necessary for receptor dimerization and activation
M Kong-Beltran et al.
CANCER CELL (2004)
Neuroendocrine cell differentiation in the CWR22 human prostate cancer xenograft: Association with tumor cell proliferation prior to recurrence
WJ Huss et al.
PROSTATE (2004)
Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model
R Meuwissen et al.
CANCER CELL (2003)
Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model
PJ Kaplan-Lefko et al.
PROSTATE (2003)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model
MY Gabril et al.
GENE THERAPY (2002)
A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49
LD True et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Prognostic factors in pancreatic endocrine neoplasms: An analysis of 136 cases with a proposal for low-grade and intermediate-grade groups
SN Hochwald et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression
B Kwabi-Addo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling
U Cavallaro et al.
NATURE CELL BIOLOGY (2001)
Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC)
T Shibayama et al.
LUNG CANCER (2001)
Share Paper
